Dosage Form Development is a collaborative process to match client product specifications with product stability characteristics to ensure effective clinical presentation. Evaluating dosage form options during the early stages of product development will ensure that the final product is tailored to meet market needs as well as agency expectations of stability.
An effective, easy to administer dosage form can increase patient compliance and minimize dosing discrepancies during clinical trials. A change in dosage form can also offer a competitive advantage.
Formatech develops the following dosage forms:
- Parenterals: liquid, lyophilized
- High concentration monoclonal antibodies
- Controlled release: liposomes, emulsions
- Oral: tablets, capsules
- Nebulized
- Topicals: gels, ointments, creams
